Ad-MAGEA3
Sponsors
Turnstone Biologics, Corp.
Conditions
Metastatic MelanomaNon-Small Cell Lung CancerSquamous Cell Skin Carcinoma
Phase 1
Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients
CompletedNCT02879760
Start: 2017-03-08End: 2020-05-24Updated: 2020-10-06
MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneous Squamous Cell Carcinoma
WithdrawnNCT03773744
Start: 2020-02-15End: 2021-12-31Updated: 2021-04-06